Because multiple receptor tyrosine kinases are overexpressed in thyroid cancer, TKIs may also represent new strategies in treating advanced thyroid cancers via targeting signaling by VEGF and its receptors. Here, NTRK1 is linked to thyroid gland carcinoma.